Development and evaluation of topical films containing phytoestrogenic diaryheptanoids from Curcuma comosa extract

References

• Falla TJ, Zhang L. Efficacy of hexapeptide-7 on menopausal skin. J Drugs Dermatol. 2010;9:49–54.
   PubMed Web of Science ®Google Scholar
• Sator PG, Schmidt JB, Rabe T, et al. Skin aging and sex hormones in women - clinical perspectives for intervention by hormone replacement therapy. Exp Dermatol. 2004;13(Suppl. 4):36–40.
   PubMed Web of Science ®Google Scholar
• Stevenson S, Thornton J. Effect of estrogens on skin aging and the potential role of SERMs. Clin Interv Aging. 2007;2:283–297.
   PubMed Web of Science ®Google Scholar
• Verdier-Sevrain S. Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators. Climacteric. 2007;10:289–297.
   PubMed Web of Science ®Google Scholar
• Thornton MJ. The biological actions of estrogens on skin. Exp Dermatol. 2002;11:487–502.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–333.
   PubMed Web of Science ®Google Scholar
• Beral VRG, Bull D, Green J. Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J Natl Cancer Inst. 2011;103:10.
   Google Scholar
• Pritchard KI. Breast cancer prevention with selective estrogen receptor modulators: a perspective. Ann N Y Acad Sci. 2001;949:89–98.
   PubMed Web of Science ®Google Scholar
• Malaivijitnond S. Medical applications of phytoestrogens from the Thai herb Pueraria mirifica. Front Med. 2012;6:8–21.
   PubMedGoogle Scholar
• Lin VC, Ding HY, Tsai PC, et al. In vitro and in vivo melanogenesis inhibition by biochanin A from Trifolium pratense. Biosci Biotechnol Biochem. 2011;75:914–918.
   PubMed Web of Science ®Google Scholar
• Widyarini S. Protective effect of the isoflavone equol against DNA damage induced by ultraviolet radiation to hairless mouse skin. J Vet Sci. 2006;7:217–223.
   PubMed Web of Science ®Google Scholar
• Yingngam BRW. Molecular and clinical role of phytoestrogens as anti-skin-ageing agents: a critical overview. Phytopharmacology. 2012;3:18.
   Google Scholar
• Sator PG. Skin treatments and dermatological procedures to promote youthful skin. Clin Interv Aging. 2006;1:51–56.
   PubMed Web of Science ®Google Scholar
• Kaewamatawong R, Boonchoong P, Teerawatanasuk N. Diarylheptanoids from Curcuma comosa. Phytochem Lett. 2009;2:4.
   Web of Science ®Google Scholar
• Suksamrarn A, Ponglikitmongkol M, Wongkrajang K, et al. Diarylheptanoids, new phytoestrogens from the rhizomes of Curcuma comosa: isolation, chemical modification and estrogenic activity evaluation. Bioorg Med Chem. 2008;16:6891–6902.
   PubMed Web of Science ®Google Scholar
• Winuthayanon W, Piyachaturawat P, Suksamrarn A, et al. Diarylheptanoid phytoestrogens isolated from the medicinal plant Curcuma comosa: biologic actions in vitro and in vivo indicate estrogen receptor-dependent mechanisms. Environ Health Perspect. 2009;117:1155–1161.
   PubMed Web of Science ®Google Scholar
• Jongkon N, Tangyuenyongwatana P. Molecular binding modes of diarylheptanoids from Curcuma comosa on the ER-β receptor. Thai J Pharm Sci. 2014;38:8.
   Google Scholar
• Su J, Sripanidkulchai B, Sripanidkulchai K, et al. Effect of Curcuma comosa and estradiol on the spatial memory and hippocampal estrogen receptor in the post-training ovariectomized rats. J Nat Med. 2011;65:57–62.
   PubMed Web of Science ®Google Scholar
• Yingngam B, Supaka N, Rungseevijitprapa W. Estrogen-like activities and cytotoxicity effects of Thai herbal medicines as natural ingredients in anti-ageing. J Med Plants Res. 2011;5:6832–6838.
   Google Scholar
• Mehdizadeh A, Toliate T, Rouini MR, et al. Design and in vitro evaluation of new drug-in-adhesive formulations of fentanyl transdermal patches. Acta Pharm. 2004;54:301–317.
   PubMedGoogle Scholar
• Feldstein MM, Tohmakhchi VN, Malkhazov LB, et al. Hydrophilic polymeric matrices for enhanced transdermal drug delivery. Int J Pharm. 1999;131:12.
   Google Scholar
• Gannu R, Vishnu YV, Kishan V, et al. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties. PDA J Pharm Sci Technol. 2008;62:391–401.
   PubMedGoogle Scholar
• Tuntiyasawasdikul S, Limpongsa E, Jaipakdee N, et al. Effects of vehicles and enhancers on the skin permeation of phytoestrogenic diarylheptanoids from Curcuma comosa. AAPS PharmSciTech. 2017;18:895–903.
   PubMed Web of Science ®Google Scholar
• Devi VK, Saisivam S, Maria GR, et al. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride. Drug Dev Ind Pharm. 2003;9:495–503.
   Google Scholar
• Arora P, Mukherjee P. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci. 2002;91:2076–2089.
   PubMed Web of Science ®Google Scholar
• Shabbir M, Fazli AR, Ali S, et al. Effect of hydrophilic and hydrophobic polymer on in vitro dissolution and permeation of bisoprolol fumarate through transdermal patch. Acta Pol Pharm. 2017;74:187–197.
   PubMed Web of Science ®Google Scholar
• Tuntiyasawasdikul S, Limpongsa E, Jaipakdee N, et al. A monolithic drug-in-adhesive patch of methoxyflavones from Kaempferia parviflora: in vitro and in vivo evaluation. Int J Pharm. 2015;478:486–495.
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123–133.
   PubMed Web of Science ®Google Scholar
• Perioli L, Ambrogi V, Angelici F, et al. Development of mucoadhesive patches for buccal administration of ibuprofen. J Control Release. 2004;99:73–82.
   PubMed Web of Science ®Google Scholar
• Ammar HO, Ghorab M, El-Nahhas SA, et al. Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part I: physicochemical evaluation. AAPS PharmSciTech. 2009;10:7–20.
   PubMed Web of Science ®Google Scholar
• Limpongsa E, Umprayn K. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system. AAPS PharmSciTech. 2008;9:464–470.
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Owen SC, editor. Handbook of pharmaceutical excipients. Pharmaceutical press: Great Britain; 2006.
   Google Scholar
• Borgquist P, Korner A, Piculell L, et al. A model for the drug release from a polymer matrix tablet-effects of swelling and dissolution. J Control Release. 2006;113:216–225.
   PubMed Web of Science ®Google Scholar
• Bodmeier R, Paeratakul O. Evaluation of drug containing polymer films prepared from aqueous latexes. Pharm Res. 1989;6:725–730.
   PubMed Web of Science ®Google Scholar
• Irfani GSR, Tondare A, Shivanand N. Design and evaluation of transdermal drug delivery system of valsartan using glycerine as plasticizer. Int J Pharm Res Dev. 2011;3:8.
   Google Scholar
• Rajabalaya RDSRK, Khanam K, Nanda A. Studies on the effect of plasticizer on in vitro release and ex vivo permeation from Eudragit E 100 based chlorpheniramine maleate matrix type transdermal delivery system. J Excipients Food Chem. 2010;1:10.
   Google Scholar
• Arifin DY, Lee LY, Wang CH. Mathematical modeling and simulation of drug release from microspheres: implications to drug delivery systems. Adv Drug Deliv Rev. 2006;58:1274–1325.
   PubMed Web of Science ®Google Scholar
• Tirunagari M, Jangala VR, Khagga M, et al. Transdermal therapeutic system of isradipine: effect of hydrophilic and hydrophobic matrix on in vitro and ex vivo characteristics. Arch Pharm Res. 2010;33:1025–1033.
   PubMed Web of Science ®Google Scholar
• Madishetti SK, Palem CR, Gannu R, et al. Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization. DARU. 2010;18:221–229.
   PubMed Web of Science ®Google Scholar
• Rougier ADD, Lotte C, et al. In vivo correlation between stratum corneum reservoir function and percutaneous absorption. J Invest Dermatol. 1983;81:275–278.
   PubMed Web of Science ®Google Scholar
• Sullivan DW Jr, Gad SC, Julien M. A review of the nonclinical safety of Transcutol®, a highly purified form of diethylene glycol monoethyl ether (DEGEE) used as a pharmaceutical excipient. Food Chem Toxicol. 2014;72:40–50.
   PubMed Web of Science ®Google Scholar
• Ritschel WA, Panchagnula R, Stemmer K, et al. Development of an intracutaneous depot for drugs. Binding, drug accumulation and retention studies, and mechanism of depot. Skin Pharmacol Physiol. 1991;4:235–245.
   Google Scholar
• Panchagnula R, Ritschel WA. Development and evaluation of an intracutaneous depot formulation of corticosteroids using Transcutol as a cosolvent: in-vitro, ex-vivo and in-vivo rat studies. J Pharm Pharmacol. 1991;43:609–614.
   PubMed Web of Science ®Google Scholar
• Godwin DA, Kim NH, Felton LA. Influence of Transcutol CG on the skin accumulation and transdermal permeation of ultraviolet absorbers. Eur J Pharm Biopharm. 2002;53:23–27.
   PubMed Web of Science ®Google Scholar